ArticleFrontiers in oncology2022

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group.

Konrad Klinghammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.